Disruption of mitochondrial homeostasis in chronic kidney disease: a mini-review

Area of Science:

• Nephrology
• Mitochondrial Biology
• Pathophysiology

Background:

• Chronic kidney disease (CKD) is a significant global health concern.
• CKD progression leads to severe complications, increased morbidity, and mortality.
• Current treatments for CKD are limited, necessitating novel therapeutic strategies.

Purpose of the Study:

• To summarize current knowledge on mitochondrial homeostasis in the context of CKD.
• To review recent advancements in mitochondria-targeting therapies for CKD.
• To highlight the critical role of mitochondria in kidney function and disease.

Main Methods:

• Literature review of studies on mitochondrial homeostasis and CKD.
• Analysis of research on mitochondria-related therapeutic approaches.
• Synthesis of current understanding and future directions in the field.

Main Results:

• Mitochondrial dysfunction is implicated in the progression of CKD.
• Kidney mitochondria are vital for normal renal function due to high energy demands.
• Emerging therapies focus on targeting mitochondria to treat kidney disease.

Conclusions:

• Maintaining mitochondrial homeostasis is crucial for kidney health.
• Mitochondria-targeted therapies represent a promising avenue for CKD treatment.
• Further research is needed to develop effective mitochondria-based interventions for CKD.